Article
Induction of phenotypic changes in SCLC cell lines in vitro by hexamethylene bisacetamide, sodium butyrate, and cyclic AMP.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jun 1993
Khan M Z, Freshney R I, McNicol A M, Murray A M
Abstract excerpt
BACKGROUND: Hexamethylene bisacetamide (HMBA), sodium butyrate (NaBt), and cyclic AMP (cAMP) have been shown to induce differentiation, which may regulate tumour growth differently from conventional cytotoxic drugs. It was the intention in the present study to determine whether alterations could be induced in the phenotype of small cell lung cancer (SCLC) cell lines with HMBA, NaBt and cAMP, and whether these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
